chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Mobility decreased, Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: Arm hurt; Cannot lift arm; Red rash around the injection site; Red rash around the injection site; Red rash around the injection site which itches; Fever of 99.6F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), MOBILITY DECREASED (Cannot lift arm), VACCINATION SITE RASH (Red rash around the injection site), VACCINATION SITE ERYTHEMA (Red rash around the injection site) and VACCINATION SITE PRURITUS (Red rash around the injection site which itches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 028A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy (Hives), Drug allergy (Hives), Crohn's disease since 01-Jun-2020 and Cystitis interstitial since 01-Jul-1987. Concomitant products included VITAMIN D3 for Osteoporosis.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt), MOBILITY DECREASED (Cannot lift arm), VACCINATION SITE RASH (Red rash around the injection site), VACCINATION SITE ERYTHEMA (Red rash around the injection site), VACCINATION SITE PRURITUS (Red rash around the injection site which itches) and PYREXIA (Fever of 99.6F). On 27-Oct-2021, PYREXIA (Fever of 99.6F) had resolved. On 28-Oct-2021, PAIN IN EXTREMITY (Arm hurt), MOBILITY DECREASED (Cannot lift arm), VACCINATION SITE RASH (Red rash around the injection site), VACCINATION SITE ERYTHEMA (Red rash around the injection site) and VACCINATION SITE PRURITUS (Red rash around the injection site which itches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Oct-2021, Body temperature: 99.6 (High) 99.6 Degree Fahrenheit.         No treatment medication information was provided.  The patient stated that she had "very slight fever for 24 hours". The patient also mentioned that the day of the call (27Oct2021) she  ad "hardly any pain" and that her arm "didn't hurt that much", it was "pretty much gone".   This case was linked to MOD-2021-366442, MOD-2021-366456 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Nov-2021: The follow up document was received and Outcome of event Pain in arm updated to recovering/resolving. On 03-Nov-2021: Significant follow up received contains patient demographic data, relevant medical history, event stop date and outcome added and updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Arm hurt; Cannot lift arm; Red rash around the injection site; Red rash around the injection site; Red rash around the injection site which itches; Fever of 99.6F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), MOBILITY DECREASED (Cannot lift arm), VACCINATION SITE RASH (Red rash around the injection site), VACCINATION SITE ERYTHEMA (Red rash around the injection site) and VACCINATION SITE PRURITUS (Red rash around the injection site which itches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 028A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy (Hives), Drug allergy (Hives), Crohn's disease since 01-Jun-2020 and Cystitis interstitial since 01-Jul-1987. Concomitant products included VITAMIN D3 for Osteoporosis.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt), MOBILITY DECREASED (Cannot lift arm), VACCINATION SITE RASH (Red rash around the injection site), VACCINATION SITE ERYTHEMA (Red rash around the injection site), VACCINATION SITE PRURITUS (Red rash around the injection site which itches) and PYREXIA (Fever of 99.6F). On 27-Oct-2021, PYREXIA (Fever of 99.6F) had resolved. On 28-Oct-2021, PAIN IN EXTREMITY (Arm hurt), MOBILITY DECREASED (Cannot lift arm), VACCINATION SITE RASH (Red rash around the injection site), VACCINATION SITE ERYTHEMA (Red rash around the injection site) and VACCINATION SITE PRURITUS (Red rash around the injection site which itches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Oct-2021, Body temperature: 99.6 (High) 99.6 Degree Fahrenheit.         No treatment medication information was provided.  The patient stated that she had "very slight fever for 24 hours". The patient also mentioned that the day of the call (27Oct2021) she  ad "hardly any pain" and that her arm "didn't hurt that much", it was "pretty much gone".   This case was linked to MOD-2021-366442, MOD-2021-366456 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Nov-2021: The follow up document was received and Outcome of event Pain in arm updated to recovering/resolving. On 03-Nov-2021: Significant follow up received contains patient demographic data, relevant medical history, event stop date and outcome added and updated.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Palpitations, SARS-CoV-2 test
Clinical narrative: Heart races faster/heart was racing a little faster; Cramps in the toes; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart races faster/heart was racing a little faster) and MUSCLE SPASMS (Cramps in the toes) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 048A21A) for COVID-19 vaccination.     The patient's past medical history included Breathing difficult (Could not breath very well on 2020 doesn't know if got COVID, but results were always negative.) in 2020.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart races faster/heart was racing a little faster) and MUSCLE SPASMS (Cramps in the toes). At the time of the report, PALPITATIONS (Heart races faster/heart was racing a little faster) and MUSCLE SPASMS (Cramps in the toes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, SARS-CoV-2 test: negative (Negative) got a test it came negative..         The patient also stated that could not breath very well on 2020 doesn't know if got COVID, may have it been hypochondria or may I have it. By the time I got a test it came negative. The patient also said my respiratory has not been the same and said that uses a couple of inhalers every day.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: follow-up received on 02-NOV-2021 contains Third dose was added.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Dose administered beyond 30 day use by date; Improper storage of product in use; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (Improper storage of product in use) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (Improper storage of product in use). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (Improper storage of product in use) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.  The vial was stored in refrigerator on 31-Aug-2021 and the date of administration was between 30-Sep-2021 to 27-Oct-2021. The vial did not undergo any temperature excursions.  It was reported that the vaccine administered between 01-Sep-2021 to 12-Oct-2021 maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccines administered between 13-Oct-2021 to 19-Oct-2021 likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration; however, some vaccine may have activity below the level studied in our clinical trials. The vaccines administered on or after 20-Oct-2021 likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.  Company Comment: This spontaneous case concerns patients of unknown age and gender (invalid case), with reported expired product administered and Improper storage of product in use and no associated events. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.  Additional information was requested.   Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Follow up received: Additional information in narrative was updated.; Sender's Comments: This spontaneous case concerns patients of unknown age and gender (invalid case), with reported expired product administered and Improper storage of product in use and no associated events. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.  Additional information was requested.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: Random chest pain after first dose; Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose; Tingling on fingers after first dose; Fingers getting numb after first dose; Pain in both entire arms after first dose; Lightheaded after first dose; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Random chest pain after first dose), VAGINAL HAEMORRHAGE (Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose), PARAESTHESIA (Tingling on fingers after first dose), HYPOAESTHESIA (Fingers getting numb after first dose) and PAIN IN EXTREMITY (Pain in both entire arms after first dose) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 25-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced CHEST PAIN (Random chest pain after first dose), VAGINAL HAEMORRHAGE (Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose), PARAESTHESIA (Tingling on fingers after first dose), HYPOAESTHESIA (Fingers getting numb after first dose), PAIN IN EXTREMITY (Pain in both entire arms after first dose) and DIZZINESS (Lightheaded after first dose). At the time of the report, CHEST PAIN (Random chest pain after first dose), VAGINAL HAEMORRHAGE (Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose), PARAESTHESIA (Tingling on fingers after first dose), HYPOAESTHESIA (Fingers getting numb after first dose), PAIN IN EXTREMITY (Pain in both entire arms after first dose) and DIZZINESS (Lightheaded after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Motrin at home for the treatment of COVID-19. She states that she did not have chest pain and heavy vaginal bleeding prior to vaccination. No concomitant medication was provided. Patient had her period on time on 23-Oct-2021 and was bleeding normal prior to vaccination.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Random chest pain after first dose; Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose; Tingling on fingers after first dose; Fingers getting numb after first dose; Pain in both entire arms after first dose; Lightheaded after first dose; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Random chest pain after first dose), VAGINAL HAEMORRHAGE (Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose), PARAESTHESIA (Tingling on fingers after first dose), HYPOAESTHESIA (Fingers getting numb after first dose) and PAIN IN EXTREMITY (Pain in both entire arms after first dose) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 25-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced CHEST PAIN (Random chest pain after first dose), VAGINAL HAEMORRHAGE (Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose), PARAESTHESIA (Tingling on fingers after first dose), HYPOAESTHESIA (Fingers getting numb after first dose), PAIN IN EXTREMITY (Pain in both entire arms after first dose) and DIZZINESS (Lightheaded after first dose). At the time of the report, CHEST PAIN (Random chest pain after first dose), VAGINAL HAEMORRHAGE (Blood clots vaginal bleeding after first dose/A lot of vaginal bleeding after first dose), PARAESTHESIA (Tingling on fingers after first dose), HYPOAESTHESIA (Fingers getting numb after first dose), PAIN IN EXTREMITY (Pain in both entire arms after first dose) and DIZZINESS (Lightheaded after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Motrin at home for the treatment of COVID-19. She states that she did not have chest pain and heavy vaginal bleeding prior to vaccination. No concomitant medication was provided. Patient had her period on time on 23-Oct-2021 and was bleeding normal prior to vaccination.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The HCP administered an expired Moderna Vaccine to the patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient). On 15-Jan-2021, EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications details were provided. No Treatment Medications details were provided.   This case was linked to MOD-2021-366988, MOD-2021-367774 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Vaccination site pain
Clinical narrative: Arm is sore stillbut improving; achy; felt fatigue; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy), FATIGUE (felt fatigue), FATIGUE (tired) and VACCINATION SITE PAIN (Arm is sore stillbut improving) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01M20A, 013L20A and 045C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (achy), FATIGUE (felt fatigue) and FATIGUE (tired). On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is sore stillbut improving). At the time of the report, PAIN (achy), FATIGUE (felt fatigue), FATIGUE (tired) and VACCINATION SITE PAIN (Arm is sore stillbut improving) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant and treatment medications are provided by the reporter.   This case was linked to MOD-2021-366366 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Nov-2021: Follow-up document received, included Vaccination site pain added as event. outcome of events updated from unknown to Recovering/Resolving.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchy at injection site/ It was hurting; itchy at injection site/ It was hurting; This morning he was tired.; He had headache.; Early this morning, his arm at the injection site was swollen./It is swelled; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (itchy at injection site/ It was hurting), VACCINATION SITE SWELLING (Early this morning, his arm at the injection site was swollen./It is swelled), VACCINATION SITE PRURITUS (itchy at injection site/ It was hurting), FATIGUE (This morning he was tired.) and HEADACHE (He had headache.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced VACCINATION SITE SWELLING (Early this morning, his arm at the injection site was swollen./It is swelled), FATIGUE (This morning he was tired.) and HEADACHE (He had headache.). On an unknown date, the patient experienced VACCINATION SITE PAIN (itchy at injection site/ It was hurting) and VACCINATION SITE PRURITUS (itchy at injection site/ It was hurting). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency; IBUPROFEN (ADVILCAPS) at an unspecified dose and frequency and DIPHENHYDRAMINE, PARACETAMOL, PHENYLPROPANOLAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE;PARACETAMOL;PHENYLPROPANOLAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (itchy at injection site/ It was hurting), VACCINATION SITE SWELLING (Early this morning, his arm at the injection site was swollen./It is swelled), VACCINATION SITE PRURITUS (itchy at injection site/ It was hurting), FATIGUE (This morning he was tired.) and HEADACHE (He had headache.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications include Blood Pressure Medicine, Heart Medicine  treatment medications include Tylenol, Advil, Benadryl
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm sore at the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm sore at the injection) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A. and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm sore at the injection). At the time of the report, VACCINATION SITE PAIN (Arm sore at the injection) outcome was unknown.            Patient took medication to help with symptoms 6 hours later. Patient was taking eye drops for glaucoma taking other medication.  No treatment medication was provided   This case was linked to MOD-2021-367411, MOD-2021-367368 (Patient Link).
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered with an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine). On 28-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Alanine aminotransferase, Aspartate aminotransferase, Blood phosphorus, Computerised tomogram
Clinical narrative: enlarged lymph node; nauseous; Her hands became itchy; unable to eat solid food/not able to hold down food; pain (stomach); lost 10 pounds; liver not functioning properly; A little sick/immune system was not liking it very much; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (A little sick/immune system was not liking it very much), PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)) and WEIGHT LOSS POOR (lost 10 pounds) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced ILLNESS (A little sick/immune system was not liking it very much). In September 2021, the patient experienced PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)), WEIGHT LOSS POOR (lost 10 pounds), HEPATIC FUNCTION ABNORMAL (liver not functioning properly) and NAUSEA (nauseous). On 24-Sep-2021, the patient experienced LYMPHADENOPATHY (enlarged lymph node). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in September 2021 for Nausea, at an unspecified dose and frequency; ONDANSETRON in September 2021 for Nausea, at an unspecified dose and frequency and DICYCLOVERINE HYDROCHLORIDE (BENTYL) in September 2021 for Nausea, at an unspecified dose and frequency. At the time of the report, ILLNESS (A little sick/immune system was not liking it very much), PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)), WEIGHT LOSS POOR (lost 10 pounds) and NAUSEA (nauseous) outcome was unknown, HEPATIC FUNCTION ABNORMAL (liver not functioning properly) was resolving and LYMPHADENOPATHY (enlarged lymph node) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Alanine aminotransferase: high (High) Alanine aminotransferase was high. In September 2021, Aspartate aminotransferase: high (High) Aspartate aminotransferase was high. In September 2021, Blood phosphorus: high (High) Blood phosphorus was high. On 24-Sep-2021, Computerised tomogram: abnormal (abnormal) Computerised tomogram scan with contrast finding an enlarged lymph node in the lower right quadrant of her stomach region where her liver is located.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient's enzyme levels were returning to normal and her lymph node has returned to normal size.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Hepatic function abnormal, Illness, Lymphadenopathy, Nausea
Clinical narrative: enlarged lymph node; nauseous; Her hands became itchy; unable to eat solid food/not able to hold down food; pain (stomach); lost 10 pounds; liver not functioning properly; A little sick/immune system was not liking it very much; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (A little sick/immune system was not liking it very much), PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)) and WEIGHT LOSS POOR (lost 10 pounds) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced ILLNESS (A little sick/immune system was not liking it very much). In September 2021, the patient experienced PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)), WEIGHT LOSS POOR (lost 10 pounds), HEPATIC FUNCTION ABNORMAL (liver not functioning properly) and NAUSEA (nauseous). On 24-Sep-2021, the patient experienced LYMPHADENOPATHY (enlarged lymph node). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in September 2021 for Nausea, at an unspecified dose and frequency; ONDANSETRON in September 2021 for Nausea, at an unspecified dose and frequency and DICYCLOVERINE HYDROCHLORIDE (BENTYL) in September 2021 for Nausea, at an unspecified dose and frequency. At the time of the report, ILLNESS (A little sick/immune system was not liking it very much), PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)), WEIGHT LOSS POOR (lost 10 pounds) and NAUSEA (nauseous) outcome was unknown, HEPATIC FUNCTION ABNORMAL (liver not functioning properly) was resolving and LYMPHADENOPATHY (enlarged lymph node) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Alanine aminotransferase: high (High) Alanine aminotransferase was high. In September 2021, Aspartate aminotransferase: high (High) Aspartate aminotransferase was high. In September 2021, Blood phosphorus: high (High) Blood phosphorus was high. On 24-Sep-2021, Computerised tomogram: abnormal (abnormal) Computerised tomogram scan with contrast finding an enlarged lymph node in the lower right quadrant of her stomach region where her liver is located.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient's enzyme levels were returning to normal and her lymph node has returned to normal size.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Weight loss poor
Clinical narrative: enlarged lymph node; nauseous; Her hands became itchy; unable to eat solid food/not able to hold down food; pain (stomach); lost 10 pounds; liver not functioning properly; A little sick/immune system was not liking it very much; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (A little sick/immune system was not liking it very much), PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)) and WEIGHT LOSS POOR (lost 10 pounds) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced ILLNESS (A little sick/immune system was not liking it very much). In September 2021, the patient experienced PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)), WEIGHT LOSS POOR (lost 10 pounds), HEPATIC FUNCTION ABNORMAL (liver not functioning properly) and NAUSEA (nauseous). On 24-Sep-2021, the patient experienced LYMPHADENOPATHY (enlarged lymph node). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in September 2021 for Nausea, at an unspecified dose and frequency; ONDANSETRON in September 2021 for Nausea, at an unspecified dose and frequency and DICYCLOVERINE HYDROCHLORIDE (BENTYL) in September 2021 for Nausea, at an unspecified dose and frequency. At the time of the report, ILLNESS (A little sick/immune system was not liking it very much), PRURITUS (Her hands became itchy), FEEDING DISORDER (unable to eat solid food/not able to hold down food), ABDOMINAL PAIN UPPER (pain (stomach)), WEIGHT LOSS POOR (lost 10 pounds) and NAUSEA (nauseous) outcome was unknown, HEPATIC FUNCTION ABNORMAL (liver not functioning properly) was resolving and LYMPHADENOPATHY (enlarged lymph node) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Alanine aminotransferase: high (High) Alanine aminotransferase was high. In September 2021, Aspartate aminotransferase: high (High) Aspartate aminotransferase was high. In September 2021, Blood phosphorus: high (High) Blood phosphorus was high. On 24-Sep-2021, Computerised tomogram: abnormal (abnormal) Computerised tomogram scan with contrast finding an enlarged lymph node in the lower right quadrant of her stomach region where her liver is located.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient's enzyme levels were returning to normal and her lymph node has returned to normal size.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2021-367500 (Patient Link).
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pruritus
Clinical narrative: injection site itch; pain in  knee; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itch) and ARTHRALGIA (pain in  knee) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced ARTHRALGIA (pain in  knee). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (injection site itch). At the time of the report, VACCINATION SITE PRURITUS (injection site itch) was resolving and ARTHRALGIA (pain in  knee) had resolved.            Concomitant medications were not provided. Treatment information was not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Tenderness, Vaccination site erythema
Clinical narrative: redness around the injection site; tenderness in his arm for a day; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness in his arm for a day) and VACCINATION SITE ERYTHEMA (redness around the injection site) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04R20A) for COVID-19 vaccination.     Concurrent medical conditions included CLL (At baseline.). Concomitant products included LEVOTHYROXINE and DOXAZOSIN for an unknown indication.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness around the injection site). On an unknown date, the patient experienced TENDERNESS (tenderness in his arm for a day). At the time of the report, TENDERNESS (tenderness in his arm for a day) had resolved and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Antibody test: greater than 128 (High) antibody titers greater than 128.         Treatment information was unknown.    This case was linked to MOD-2021-367566, MOD-2021-367614 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Aches; Fever of 101; Weird headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Aches), HEADACHE (Weird headache) and PYREXIA (Fever of 101) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 071F21A) for COVID-19 vaccination.     Concurrent medical conditions included Selective IgM immunodeficiency (Low IgM an autoimmune thing.).   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Weird headache). On 06-Mar-2021, the patient experienced MYALGIA (Aches) and PYREXIA (Fever of 101). On 06-Mar-2021, HEADACHE (Weird headache) had resolved. On 06-Mar-2021 at 5:00 PM, MYALGIA (Aches) and PYREXIA (Fever of 101) had resolved.            Patient's Past medical History stated history of low IgM an autoimmune thing. She doesn't build a lot of antibodies. No concomitant medications were mentioned. Treatment medication reported included Long acting arthritis Tylenol which was used after 3rdd dose.   This case was linked to MOD-2021-367692 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Pyrexia
Clinical narrative: Skin felt warm/Temperature was 100.1 degrees Fahrenheit; Muscle Aches/Aches in her neck/Aches in her shoulders; Headache like she had never had before in her life; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Skin felt warm/Temperature was 100.1 degrees Fahrenheit), MYALGIA (Muscle Aches/Aches in her neck/Aches in her shoulders) and HEADACHE (Headache like she had never had before in her life) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A, 012A21A and 004MZ("0" or "O")A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA (Skin felt warm/Temperature was 100.1 degrees Fahrenheit), MYALGIA (Muscle Aches/Aches in her neck/Aches in her shoulders) and HEADACHE (Headache like she had never had before in her life). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 01-Mar-2021, PYREXIA (Skin felt warm/Temperature was 100.1 degrees Fahrenheit), MYALGIA (Muscle Aches/Aches in her neck/Aches in her shoulders) and HEADACHE (Headache like she had never had before in her life) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 100.1 (High) 100.1 degrees.         Concomitant medication information was not provided by the reporter.   This case was linked to MOD-2021-368122 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired dose was given to a patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose was given to a patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose was given to a patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose was given to a patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Follow-up was received on 2-NOV-2021 and contains no new information.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Fatigue; Chills; Muscle pain; Joint pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A, 010M20A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were provided.  Patient was taking other medication (unspecified).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered after 30-day Use By Date/gave 81 doses of the Moderna Covid-19 Vaccine after the vials were stored in the refrigerator for 30 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date/gave 81 doses of the Moderna Covid-19 Vaccine after the vials were stored in the refrigerator for 30 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date/gave 81 doses of the Moderna Covid-19 Vaccine after the vials were stored in the refrigerator for 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date/gave 81 doses of the Moderna Covid-19 Vaccine after the vials were stored in the refrigerator for 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 19-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 19-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.            No treatment information was provided.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 19-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Patient received vaccine in deltoid.   This case was linked to MOD-2021-361706 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment information was provided.  Patient took vaccine on Deltoid.   This case was linked to MOD-2021-361706 (Patient Link).
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: right arm became a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (right arm became a little sore) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (right arm became a little sore). At the time of the report, VACCINATION SITE PAIN (right arm became a little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information provided.   This case was linked to MOD-2021-368775, MOD-2021-368774 (Patient Link).